Microbicide Trials Network

MTN-013/IPM 026


A Phase I safety and drug absorption study of a vaginal ring containing either dapivirine, maraviroc or the two antiretroviral drugs combined. The study was the first clinical trial of a vaginal ring containing maraviroc and the first to test a vaginal ring with two active drugs. It was conducted in collaboration with the International Partnership for Microbicides.

 

See

First Trial of Combination ARV Vaginal Ring for HIV Prevention Finds Ring Safe but One ARV Carrying the Weight

4-March-2014

  

MTN-013/IPM 026 Q&A

4-March-2014

  

First Combination ARV Vaginal Ring for HIV Prevention Being Tested in Phase I Safety Trial

15-November-2011

 

See also

MTN-013/IPM 026 Protocol